Ileal Conduit Versus Orthotopic Neobladder Urinary Diversion in Robot-assisted Radical Cystectomy: Results from a Multi-institutional Series. 2023

Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
Department of Urology, IRCCS Policlinico San Martino, Genova, Italy.

Head-to-head comparisons between ileal conduit (IC) and orthotopic neobladder (ONB) in terms of peri- and postoperative outcomes and complications, in the specific setting of robot-assisted radical cystectomy (RARC), are not available. To address the impact of the type of urinary diversion (UD, IC vs ONB) on RARC morbidity, as well as operative time (OT), length of stay (LOS), and readmissions. Urothelial bladder cancer patients treated with RARC at nine high-volume European institutions between 2008 and 2020 were identified. RARC with either IC or ONB. Intra- and postoperative complications were collected and reported according to the Intraoperative Complications Assessment and Reporting with Universal Standards recommendations and European Association of Urology guidelines, respectively. Multivariable logistic regression models tested the impact of UD on outcomes, after adjustment for clustering at single hospital level. Overall, 555 nonmetastatic RARC patients were identified. In 280 (51%) and 275 (49%) patients, an IC and an ONB were performed, respectively. Eighteen intraoperative complications were recorded. The rates of intraoperative complications were 4% in IC patients and 3% in ONB patients (p = 0.4). The median LOS and readmission rates were 10 versus 12 d (p < 0.001) and 20% versus 21% (p = 0.8) in IC versus ONB patients, respectively. At a multivariable logistic regression analyses, the type of UD (IC vs ONB) reached the independent predictor status for prolonged OT (odds ratio [OR]: 0.61, p = 0.03) and prolonged LOS (OR: 0.34, p < 0.001), but not for readmission (OR: 0.92, p = 0.7). Overall, 513 postoperative complications were experienced by 324 patients (58%). At least one postoperative complication was experienced by 160 (57%) IC patients versus 164 (60%) ONB patients (p = 0.6). The type of UD reached the status of an independent predictor of UD-related complications (OR: 0.64, p = 0.03). Compared with RARC with ONB, RARC with IC is less prone to UD-related postoperative complications, prolonged OT, and prolonged LOS. To date, the impact of the type of urinary diversion, namely, ileal conduit versus orthotopic neobladder, on peri- and postoperative outcomes of robot-assisted radical cystectomy is unknown. Based on a rigorous data accrual, which relied on established complication reporting systems (Intraoperative Complications Assessment and Reporting with Universal Standards and European Association of Urology recommended systems), we reported intra- and postoperative complications according to urinary diversion type. Moreover, we found that ileal conduit was associated with lower operative time and length of stay, and yielded a protective effect in terms of urinary diversion-related complications.

UI MeSH Term Description Entries

Related Publications

Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
May 2024, Annals of surgical oncology,
Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
February 2001, Seminars in urologic oncology,
Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
June 2024, Annals of surgical oncology,
Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
October 2000, World journal of urology,
Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
March 2013, Aktuelle Urologie,
Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
October 2009, Annals of the Royal College of Surgeons of England,
Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
December 2007, Journal of endourology,
Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
November 2002, The Journal of urology,
Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
July 2021, International journal of urology : official journal of the Japanese Urological Association,
Stefano Tappero, and Paolo Dell'Oglio, and Maria Angela Cerruto, and Rafael Sanchez Salas, and Oscar Buisan Rueda, and Giuseppe Simone, and Kees Hendricksen, and Francesco Soria, and Paolo Umari, and Alessandro Antonelli, and Alberto Briganti, and Francesco Montorsi, and Ottavio de Cobelli, and Carlo Terrone, and Antonio Galfano, and Marco Moschini, and Ettore Di Trapani, and
January 2022, Frontiers in surgery,
Copied contents to your clipboard!